信邦制药(002390)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002390 信邦制药

已收盘 02-13 15:00:00

{"stockData":{"symbol":"002390","market":"SZ","secType":"STK","nameCN":"信邦制药","latestPrice":3.3,"timestamp":1770966213000,"preClose":3.34,"halted":0,"volume":23091186,"delay":0,"changeRate":-0.012,"floatShares":1928000000,"shares":1944000000,"eps":0.0397,"marketStatus":"已收盘","change":-0.04,"latestTime":"02-13 15:00:00","open":3.34,"high":3.36,"low":3.29,"amount":76755600,"amplitude":0.021,"askPrice":3.31,"askSize":3634,"bidPrice":3.3,"bidSize":1685,"shortable":0,"etf":0,"ttmEps":0.0397,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771896600000},"marketStatusCode":5,"adr":0,"adjPreClose":3.34,"symbolType":"stock","openAndCloseTimeList":[[1770946200000,1770953400000],[1770958800000,1770966000000]],"highLimit":3.67,"lowLimit":3.01,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1943851868,"isCdr":false,"pbRate":0.96,"roa":"--","peRate":83.123426,"roe":"2.25%","epsLYR":0.05,"committee":-0.259673,"marketValue":6415000000,"turnoverRate":0.012,"status":1,"floatMarketCap":6362000000},"requestUrl":"/m/hq/s/002390","defaultTab":"news","newsList":[{"id":"2608360070","title":"信邦制药（002390）披露为控股子公司提供合计3亿元担保公告，2月4日股价上涨1.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608360070","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608360070?lang=zh_cn&edition=full","pubTime":"2026-02-04 22:28","pubTimestamp":1770215299,"startTime":"0","endTime":"0","summary":"截至2026年2月4日收盘，信邦制药报收于3.36元，较前一交易日上涨1.2%，最新总市值为65.31亿元。近日，贵州信邦制药股份有限公司披露《关于为控股子公司提供担保的公告》。公告显示，公司于2026年2月3日与光大银行贵阳分行签订担保合同，为其控股子公司贵州同德药业股份有限公司提供4,000万元连带责任保证担保，担保期限为主债务履行期届满之日起三年；同时为另一控股子公司贵州科开医药有限公司提供26,000万元连带责任保证担保，担保期限相同。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400041608.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0114","BK0239","BK0004","BK0146","BK0096","BK0056","002390"],"gpt_icon":0},{"id":"2607068703","title":"信邦制药：公司自产自销的中成药产品均已完成说明书中安全性内容的修订工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2607068703","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607068703?lang=zh_cn&edition=full","pubTime":"2026-01-30 08:33","pubTimestamp":1769733186,"startTime":"0","endTime":"0","summary":"证券之星消息，信邦制药01月29日在投资者关系平台上答复投资者关心的问题。公司未来也将持续关注行业的相关动态和变化，做好日常经营管理，不断深化和挖掘产业发展潜力，确保公司在市场竞争中保持优势。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000007588.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0239","BK0056","BK0096","BK0146","BK0028","BK0004","002390"],"gpt_icon":0},{"id":"2606290574","title":"信邦制药：贵州医科大学附属白云医院设立颐康医养中心","url":"https://stock-news.laohu8.com/highlight/detail?id=2606290574","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606290574?lang=zh_cn&edition=full","pubTime":"2026-01-26 16:06","pubTimestamp":1769414779,"startTime":"0","endTime":"0","summary":"证券之星消息，信邦制药(002390)01月26日在投资者关系平台上答复投资者关心的问题。投资者提问：人口老龄化严重，贵公司在养老康复服务方面有哪些布局？信邦制药回复：您好，公司下属的贵州医科大学附属白云医院设立有颐康医养中心，致力为失能、半失能、术后需康复、生活难自理等人员提供全方位、专业化、多层次、高品质的健康养老服务；公司下属的贵州医科大学附属乌当医院与本地养老院也有长期的合作，为其提供医疗、康复及护理等服务。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600015663.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0146","002390","BK0056","BK0028","BK0239","BK0114","BK0004"],"gpt_icon":0},{"id":"2606905172","title":"信邦制药：截至2024年度拥有23个国家医保目录品种","url":"https://stock-news.laohu8.com/highlight/detail?id=2606905172","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606905172?lang=zh_cn&edition=full","pubTime":"2026-01-26 16:06","pubTimestamp":1769414778,"startTime":"0","endTime":"0","summary":"证券之星消息，信邦制药(002390)01月26日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司中药业务到目前已经有多少个加入国家医保目录品种？信邦制药回复：您好，截至2024年度，在中成药方面，公司拥有11个国家基药目录品种，23个国家医保目录品种，主要品种益心舒胶囊、脉血康胶囊、关节克痹丸（独家品种）、银杏叶片、六味安消胶囊、贞芪扶正胶囊均在国家医保目录中。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600015657.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0004","BK0028","BK0114","BK0239","BK0096","002390","BK0056"],"gpt_icon":0},{"id":"2606878263","title":"股市必读：信邦制药（002390）1月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2606878263","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606878263?lang=zh_cn&edition=full","pubTime":"2026-01-26 01:42","pubTimestamp":1769362937,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，信邦制药报收于3.43元，上涨2.69%，换手率2.88%，成交量55.52万手，成交额1.89亿元。关于补缴税款的公告贵州信邦制药股份有限公司及下属子公司根据主管税务机关要求对涉税事项开展自查，需补缴税款及滞纳金合计5,078.69万元，其中公司补缴269.57万元，下属子公司补缴4,809.12万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600000740.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0004","BK0114","BK0239","BK0146","BK0028","BK0056","002390"],"gpt_icon":0},{"id":"2606319254","title":"信邦制药最新公告：公司及下属子公司需补缴税款及滞纳金5078.69万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606319254","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606319254?lang=zh_cn&edition=full","pubTime":"2026-01-25 17:30","pubTimestamp":1769333458,"startTime":"0","endTime":"0","summary":"信邦制药(002390.SZ)公告称，经自查，公司及下属子公司需补缴税款及滞纳金5078.69万元。上述补缴税款及滞纳金将计入公司2025年当期损益。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500007586.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0004","BK0146","002390","BK0028","BK0056","BK0096","BK0239"],"gpt_icon":0},{"id":"2605142018","title":"信邦制药：公司目前暂未涉及您提及的技术运用","url":"https://stock-news.laohu8.com/highlight/detail?id=2605142018","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605142018?lang=zh_cn&edition=full","pubTime":"2026-01-23 16:30","pubTimestamp":1769157039,"startTime":"0","endTime":"0","summary":"证券之星消息，信邦制药01月23日在投资者关系平台上答复投资者关心的问题。AI技术赋能提升医疗服务效率与质量。作为贵州省医药流通龙头，公司覆盖全省95%以上等级医院及45%基层医院。公司始终对各种新技术在医疗领域的发展和运用保持关注，未来也将结合公司实际情况，对相关技术在公司业务方面的运用可能性进行积极探索。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300024295.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002390","BK0114","BK0056","BK0004","BK0239","BK0028","BK0096","BK0146"],"gpt_icon":0},{"id":"2605016432","title":"信邦制药：旗下医院开展美容医疗业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2605016432","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605016432?lang=zh_cn&edition=full","pubTime":"2026-01-22 08:48","pubTimestamp":1769042889,"startTime":"0","endTime":"0","summary":"证券之星消息，信邦制药(002390)01月21日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司旗下医院是否有美容医疗的业务？信邦制药回复：您好，公司下属贵州医科大学附属乌当医院设有整形科，目前开展有眼鼻整形、注射微整形、注射水光针、光子嫩肤等项目；下属仁怀新朝阳医院有限公司设有医美科，科室以整形美容与皮肤美容为特色构建一体化诊治体系，目前开展有面部整形、皮肤管理等项目。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200006306.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0146","BK0056","BK0004","159891","002390","BK0028","BK0096","BK0114"],"gpt_icon":0},{"id":"2604167909","title":"信邦制药：针对不实信息保留追究法律责任权利","url":"https://stock-news.laohu8.com/highlight/detail?id=2604167909","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604167909?lang=zh_cn&edition=full","pubTime":"2026-01-20 15:31","pubTimestamp":1768894266,"startTime":"0","endTime":"0","summary":"证券之星消息，信邦制药01月20日在投资者关系平台上答复投资者关心的问题。针对网络上的不实或误导性信息，公司将依据其传播范围、影响程度等因素进行评估，并对上述信息保留追究法律责任的权利。公司管理层也将始终保持勤勉尽责，通过做好日常的生产经营管理、公司治理及投资者关系管理等方面的工作，保持公司健康稳定的发展，不断提高公司的内在价值、市场形象。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012000018373.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0004","BK0096","BK0146","BK0028","002390","BK0056","BK0239","BK0114"],"gpt_icon":0},{"id":"2603762731","title":"信邦制药：坚持以医疗服务为核心业务架构","url":"https://stock-news.laohu8.com/highlight/detail?id=2603762731","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603762731?lang=zh_cn&edition=full","pubTime":"2026-01-15 11:33","pubTimestamp":1768448004,"startTime":"0","endTime":"0","summary":"证券之星消息，信邦制药01月14日在投资者关系平台上答复投资者关心的问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500015434.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002390","BK0239","BK0056","BK0004","BK0146","BK0028","BK0114","BK0096"],"gpt_icon":0},{"id":"2602550551","title":"股市必读：信邦制药（002390）1月9日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2602550551","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602550551?lang=zh_cn&edition=full","pubTime":"2026-01-12 03:24","pubTimestamp":1768159451,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，信邦制药报收于3.3元，上涨0.3%，换手率1.72%，成交量33.25万手，成交额1.09亿元。董秘最新回复投资者： 贵州省医院有否明确脑机接口植入医疗服务？关于贵州省内其他医院的相关业务开展情况，请您以医院官方网站的信息为准。感谢您对公司的关注！交易信息汇总资金流向1月9日主力资金净流出177.33万元；游资资金净流出223.91万元；散户资金净流入401.24万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200001429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002390","BK0114","BK0146","BK0004","BK0096","BK0056","BK0239"],"gpt_icon":0},{"id":"2591849199","title":"信邦制药：不存在退市或ST风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2591849199","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591849199?lang=zh_cn&edition=full","pubTime":"2025-12-16 20:51","pubTimestamp":1765889484,"startTime":"0","endTime":"0","summary":"证券之星消息，信邦制药12月15日在投资者关系平台上答复投资者关心的问题。目前公司生产经营情况一切正常，不存在触及相关法律、法规规定的其他风险警示或是退市风险警示的情形。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600038068.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0146","BK0056","002390","BK0114","BK0004","BK0096"],"gpt_icon":0},{"id":"2591753466","title":"信邦制药：下属公司销售流感相关药品","url":"https://stock-news.laohu8.com/highlight/detail?id=2591753466","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591753466?lang=zh_cn&edition=full","pubTime":"2025-12-16 08:45","pubTimestamp":1765845914,"startTime":"0","endTime":"0","summary":"证券之星消息，信邦制药(002390)12月15日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，你好，近期流感比较严重。请问贵司有涉及流感药没？信邦制药回复：您好，公司下属的医药流通公司销售有您提及的药品，并会根据市场需求进行相应备货。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600005974.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0114","BK0239","BK0004","BK0146","BK0096","BK0056","002390"],"gpt_icon":0},{"id":"2590572089","title":"12月12日信邦制药（002390）龙虎榜数据：游资章盟主上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2590572089","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590572089?lang=zh_cn&edition=full","pubTime":"2025-12-12 17:53","pubTimestamp":1765533231,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年12月12日公布的交易公开信息显示，信邦制药因日跌幅偏离值达到7%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年12月12日收盘，信邦制药报收于3.37元，下跌9.89%，换手率8.07%，成交量155.62万手，成交额5.28亿元。从龙虎榜公布的当日买卖数据来看，机构合计净卖出803.51万元，北向资金合计净卖出1449.97万元。章盟主等知名游资榜上有名。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200028821.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002390","BK0239","BK0056","BK0004","BK0146","BK0028","BK0114","BK0096"],"gpt_icon":0},{"id":"2590252758","title":"异动快报：信邦制药（002390）12月12日13点8分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2590252758","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590252758?lang=zh_cn&edition=full","pubTime":"2025-12-12 13:10","pubTimestamp":1765516250,"startTime":"0","endTime":"0","summary":"证券之星12月12日盘中消息，13点8分信邦制药（002390）触及跌停板。其所属行业中药目前下跌。领涨股为金花股份。该股为口腔，体外诊断，基因测序概念热股，当日口腔概念上涨1.58%，体外诊断概念上涨0.05%。12月11日的资金流向数据方面，主力资金净流出1.43亿元，占总成交额24.09%，游资资金净流入6170.6万元，占总成交额10.41%，散户资金净流入8105.12万元，占总成交额13.68%。近5日资金流向一览见下表：信邦制药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200017622.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0096","BK0056","BK0114","002390","BK0028","BK0146","BK0004"],"gpt_icon":0},{"id":"2590845715","title":"信邦制药(002390.SZ)：公司涉嫌单位行贿遭检查机关起诉","url":"https://stock-news.laohu8.com/highlight/detail?id=2590845715","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590845715?lang=zh_cn&edition=full","pubTime":"2025-12-10 20:15","pubTimestamp":1765368911,"startTime":"0","endTime":"0","summary":"智通财经APP讯，信邦制药(002390.SZ)公告，公司近日收到检察机关《审查起诉阶段委托辩护人/申请法律援助告知书》、《犯罪嫌疑人诉讼权利义务告知书》，主要内容为：对公司涉嫌单位行贿一案，检察机关已经收到监察委员会移送起诉的材料。根据《中华人民共和国刑事诉讼法》第三十四条、第三十五条、第二百七十八条之规定，告知公司有权委托辩护人，以及诉讼的权利义务。公告称，本次重大事项对公司的品牌声誉、业务拓展及未来发展可能会产生一定的不利影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380065.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"信邦制药(002390.SZ)：公司涉嫌单位行贿遭检查机关起诉","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0056","BK0239","002390","BK0114","BK0004","BK0146","BK0028","BK0096"],"gpt_icon":0},{"id":"2590372614","title":"异动快报：信邦制药（002390）12月10日11点29分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2590372614","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590372614?lang=zh_cn&edition=full","pubTime":"2025-12-10 11:30","pubTimestamp":1765337450,"startTime":"0","endTime":"0","summary":"证券之星12月10日盘中消息，11点29分信邦制药触及涨停板。其所属行业中药目前下跌。领涨股为马应龙。该股为医美，土地流转，民营医院概念热股，当日医美概念上涨0.11%，土地流转概念上涨0.06%，民营医院概念上涨0.02%。12月9日的资金流向数据方面，主力资金净流出1979.59万元，占总成交额15.09%，游资资金净流出695.03万元，占总成交额5.3%，散户资金净流入2674.62万元，占总成交额20.39%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121000013614.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0239","BK0056","002390","BK0004","BK0028","BK0114","BK0096"],"gpt_icon":0},{"id":"2589014867","title":"信邦制药：下属流通公司销售流感药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2589014867","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589014867?lang=zh_cn&edition=full","pubTime":"2025-12-05 16:33","pubTimestamp":1764923590,"startTime":"0","endTime":"0","summary":"证券之星消息，信邦制药(002390)12月05日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，贵公司在医药流通领域有储备流感药物吗？11月销售情况如何？信邦制药回复：您好，公司下属的医药流通公司销售有您提及的药品，并会根据市场需求进行相应备货。关于公司的经营情况，敬请您关注公司后续披露的定期报告。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500022580.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0004","BK0239","002390","BK0146","BK0028","BK0096","BK0114"],"gpt_icon":0},{"id":"2579130415","title":"信邦制药（002390）2025年三季报简析：净利润同比下降13.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579130415","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579130415?lang=zh_cn&edition=full","pubTime":"2025-10-30 06:27","pubTimestamp":1761776833,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期信邦制药发布2025年三季报。根据财报显示，信邦制药净利润同比下降13.74%。截至本报告期末，公司营业总收入42.66亿元，同比下降6.55%，归母净利润1.52亿元，同比下降13.74%。按单季度数据看，第三季度营业总收入14.21亿元，同比下降6.42%，第三季度归母净利润4512.81万元，同比下降26.87%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000005605.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002390"],"gpt_icon":0},{"id":"2578995811","title":"图解信邦制药三季报：第三季度单季净利润同比下降26.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578995811","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578995811?lang=zh_cn&edition=full","pubTime":"2025-10-28 19:04","pubTimestamp":1761649498,"startTime":"0","endTime":"0","summary":"证券之星消息，信邦制药2025年三季报显示，公司主营收入42.66亿元，同比下降6.55%；归母净利润1.52亿元，同比下降13.74%；扣非净利润1.57亿元，同比下降10.5%；其中2025年第三季度，公司单季度主营收入14.21亿元，同比下降6.42%；单季度归母净利润4512.81万元，同比下降26.87%；单季度扣非净利润5021.62万元，同比下降16.84%；负债率18.83%，投资收益26.62万元，财务费用1110.61万元，毛利率17.44%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800035368.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002390"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770976060330,"stockEarnings":[{"period":"1week","weight":-0.006},{"period":"1month","weight":-0.006},{"period":"3month","weight":-0.1608},{"period":"6month","weight":-0.0847},{"period":"1year","weight":-0.1796},{"period":"ytd","weight":0.0373}],"compareEarnings":[{"period":"1week","weight":0.0143},{"period":"1month","weight":-0.0011},{"period":"3month","weight":0.036},{"period":"6month","weight":0.1183},{"period":"1year","weight":0.2354},{"period":"ytd","weight":0.0416}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"贵州信邦制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"64321人(较上一季度减少3.56%)","perCapita":"29971股","listingDate":"2010-04-16","address":"贵州省黔南布依族苗族自治州罗甸县龙坪镇信邦大道48号","registeredCapital":"194385万元","survey":"　　贵州信邦制药股份有限公司的主营业务是以医疗服务为核心、辅以医药流通及中医药制造。公司的主要产品是药品、器械、医疗服务、其他产品。","listedPrice":33},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"信邦制药(002390)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供信邦制药(002390)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"信邦制药,002390,信邦制药股票,信邦制药股票老虎,信邦制药股票老虎国际,信邦制药行情,信邦制药股票行情,信邦制药股价,信邦制药股市,信邦制药股票价格,信邦制药股票交易,信邦制药股票购买,信邦制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"信邦制药(002390)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供信邦制药(002390)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}